Skip to content
‹ Back to IndustriesHealthcare

LabDash: Fast-Tracking COVID-19 Testing

COVID-19 tests have become such an integral part of life today that many people don’t stop to think about the laboratory technicians working behind the scenes to deliver results efficiently and accurately. However, these diligent people still face issues in their day-to-day work. LabDash aims to solve many, if not all, of them with its…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Promoted content from Pro AV Today on MarketScale.

·
Share

Free workspace

Turn your Healthcare expertise into content.

Record interviews, organize footage, and write with AI on a free trial of the MarketScale platform for qualifying companies. No demo required, no credit card.

Try it Free

COVID-19 tests have become such an integral part of life today that many people don’t stop to think about the laboratory technicians working behind the scenes to deliver results efficiently and accurately. However, these diligent people still face issues in their day-to-day work. LabDash aims to solve many, if not all, of them with its testing software service.

Manny Cruz and Moriah Biederman join host Tyler Kern to talk about LabDash, its capabilities, and what it means for patients, providers, and labs alike. Cruz is the CEO of WVT Laboratory, and Biederman is the Automation Software Engineer and Product Lead at Concept Systems; these two companies worked together to create the LabDash, making them particularly suited to discuss this topic.

“We facilitate the entire testing process from the lab’s perspective, in order to track the test kits throughout the process and facilitate data collection from the patient’s side and the provider’s side as well,” said Biederman.

As laboratories all over the world began to conduct COVID-19 testing on a massive scale, many of them realized that the intake process prevented them from doing more, even though the testing capabilities were there. Thanks to LabDash, WVT Laboratory slashed the time that intake took from two to four minutes per patient to less than 15 seconds. “We did 18,000 samples last week and we wouldn’t have been able to do that without LabDash,” revealed Cruz.

“The name of the game right now in COVID testing is speed and turnaround,” Cruz said later in the podcast. “The end result is the value. No one’s getting COVID tested for fun.”

Learn more simplifying the COVID-19 testing process for patients, providers, private sponsors and labs, here.

Pro AV Today

Part of this channel

Pro AV Today

Pro AV news, trends, and expert voices for the AV industry

Visit the channel

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Book DemoSee how it works15 minutes, straight to a calendar.
B2B Weekly

The week in Healthcare, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free Trial

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Start a free trial and see it with your own people. For qualifying companies, no credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What your free trial includes

Hands-on access to the MarketScale platform
Media requests to your crowd, remote recording, AI writing tools
No demo required. No credit card.
For qualifying companies. Company confirmation required.

More Healthcare Insights

Why CAHPS still swings Star Ratings at half its old weight

Why CAHPS still swings Star Ratings at half its old weight

mPulse’s Sam Oliver and Reva Sheehan said the CAHPS chapter moved with overall Medicare Advantage Star Ratings from 2026 to 2027 after CMS cut its weight from 4 to 2. With 11 measures slated to exit by 2029 and the equity reward cancelled, they urged quality teams to model CAHPS impacts and population mix alongside reweighting changes.

  • 01CMS cut CAHPS from a weight of 4 to 2 in the CY2025 final rule, effective with the 2026 Star Ratings, yet mPulse's chapter data shows CAHPS still moved in the same direction as overall stars for the 2027 cycle.
  • 02The April 2026 final rule removes 11 administrative measures, but none leave before the 2028 Star Ratings; the 2027 measure set is unchanged and the Health Equity Index reward is cancelled.
  • 03CAHPS stars are set by percentile cutoffs and reliability tests, and in the 2025 Star Ratings 13 percent of CAHPS results landed on a different star than the cutoff implied, 93 percent of them lower, according to RISE Health.

Nov 2, 2026

Why ECG device makers may stop rebuilding arrhythmia analysis from scratch

Why ECG device makers may stop rebuilding arrhythmia analysis from scratch

Monebo's Kinetic Software Library provides ectopic beat detection, QRS feature extraction, and heart rate and rhythm analysis for ECG devices. For ECG device engineering and regulatory teams, rhythm analysis could become a choice between building it and licensing it.

  • 01Fifty-one later FDA clearances trace their predicate lineage to Monebo's earlier libraries, a track record anyone evaluating the new one can check.

Nov 1, 2026

AI Takes Center Stage at AHA 2026. Experts Warn It Must Be Built for Everyone

AI Takes Center Stage at AHA 2026. Experts Warn It Must Be Built for Everyone

AI-enabled ECG, echocardiography and imaging studies are a major theme at the American Heart Association's Scientific Sessions 2026 in Chicago, November 6 to 9. A Frontiers in Cardiovascular Medicine policy brief led by Emory cardiologist Dr. Jose R. Medina-Inojosa argues precision cardiology must be designed with equity from inception. He says the biggest factor is not algorithm accuracy but the pathway from result to clinical action.

  • 01AHA 2026 late-breakers on AI include WATCH-LV, AI ECHO INSIGHT, PROVAR+ and LIFE-AI, all presented Monday, November 9.
  • 02Medina-Inojosa says equity from inception means training and validating on representative data and reporting subgroup performance before deployment.
  • 03Programs in Nigeria and Uganda show AI-ECG and AI-guided echo can extend cardiac care where specialists are scarce.

Nov 1, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a Demo

Or call us. No forms required. We pick up. 214-945-2512